Evidence map›Paper›PMID 33917117›Full record

ReviewMolecules (Basel, Switzerland)2021

Intrinsically Disordered Proteins as Regulators of Transient Biological Processes and as Untapped Drug Targets.

Yusuke Hosoya, Junko Ohkanda

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Intrinsic disorder in the human vitreous proteome.International journal of biological macromolecules · 2024
    Article
  7. Intrinsic Disorder in the Human Tear Proteome.Investigative ophthalmology & visual science · 2023
    Article
  8. Article
  9. Review
  10. Evolving Experimental Techniques for Structure-Based Drug Design.The journal of physical chemistry. B · 2022
    Review
  11. Review
  12. Review
  13. Deep learning in prediction of intrinsic disorder in proteins.Computational and structural biotechnology journal · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yusuke HosoyaAcademic Assembly, Institute of Agriculture, Shinshu University, 8304 Minami-Minowa, Kami-Ina, Nagano 399-4598, Japan.
Junko OhkandaAcademic Assembly, Institute of Agriculture, Shinshu University, 8304 Minami-Minowa, Kami-Ina, Nagano 399-4598, Japan.ORCID 0000-0001-9663-5104
Shinshu University · JP

Funding

Japan Society for the Promotion of Science 18H02106,20K21248Ministry of Education, Culture, Sports, Science and Technology 18H04394, 20H04769the Koyanagi Foundation 2018
6 · The paper itself

Abstract

Intrinsically disordered proteins (IDPs) are critical players in the dynamic control of diverse cellular processes, and provide potential new drug targets because their dysregulation is closely related to many diseases. This review focuses on several medicinal studies that have identified low-molecular-weight inhibitors of IDPs. In addition, clinically relevant liquid-liquid phase separations-which critically involve both intermolecular interactions between IDPs and their posttranslational modification-are analyzed to understand the potential of IDPs as new drug targets.

Indexed as

Drug DiscoverySignal TransductionAnimalsBiomarkersCarrier ProteinsHumansIntrinsically Disordered ProteinsLiquid-Liquid ExtractionProtein BindingStructure-Activity RelationshipBiomarkersCarrier ProteinsIntrinsically Disordered Proteinsdrug discoveryintrinsically disordered proteinsliquid–liquid phase separationprotein–protein interactions

Identifiers

PMID33917117
PMCPMC8067799
OpenAlexW3150581979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.